Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 20, 2017
Pharmacy Choice - Pharmacy News - February 20, 2017

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
2/20/17 - Bristol-Myers Squibb Receives FDA Approval for Opdivo nivolumab in Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma, a Type of...
Bristol-Myers Squibb Receives FDA Approval for Opdivo nivolumab in Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma, a Type of Bladder Cancer. By a News Reporter-Staff News Editor at Biotech Business Week-- Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration has approved Opdivo injection, for intraveno
2/20/17 - CureDuchenne Applauds the FDA Approval of Marathon's EMFLAZA deflazacort for the Treatment of Duchenne Muscular Dystrophy
By a News Reporter-Staff News Editor at Clinical Trials Week-- CureDuchenne applauds the U.S. Food and Drug Administration approval of EMFLAZAâ?¢, developed by Marathon Pharmaceuticals, the first drug in the U.S. approved for use by patients five and older with Duchenne muscular dystrophy regardless of genetic mutation. "For the first time all tho
2/20/17 - FDA Approves Amgen's Parsabiv Etelcalcetide, First New Treatment In More Than A Decade For Secondary Hyperparathyroidism In Adult Patients On...
By a News Reporter-Staff News Editor at Clinical Trials Week--- Amgen announced that the U.S. Food and Drug Administration has approved Parsabivâ?¢ for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis. "We are excited about today's approval of Parsabiv in the U.S. and the opportunity to p
2/20/17 - FDA Approves Bio Products Laboratory's Gammaplex® 10% for Treatment of Primary Immunodeficiency and Chronic Immune Thrombocytopenic Purpura
By a News Reporter-Staff News Editor at Clinical Trials Week-- Bio Products Laboratory Limited, a leading manufacturer of plasma-derived protein therapies, announced that the U.S. Food and Drug Administration has approved Gammaplex ® 10% for the treatment of primary immunodeficiency and chronic immune thrombocytopenic purpura in adults.
2/20/17 - First automated ANCA IFA assays cleared by FDA
By a News Reporter-Staff News Editor at Pharma Business Week--- Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced that the United States Food and Drug Administration has granted 510 clearance of NOVA Lite ® DAPI ANCA and NOVA Lite ® DAPI ANCA Kits for use with NOVA View ®,
2/20/17 - Kindred Biosciences Receives Early Approval of Effectiveness Technical Section from FDA for Mirataz New Animal Drug Application
By a News Reporter-Staff News Editor at Veterinary Week--- Kindred Biosciences, Inc., a biopharmaceutical company focused on saving and improving the lives of pets, announced it has received a technical section complete letter for effectiveness from the U.S. Richard Chin, CEO of KindredBio, stated, "This is a major milestone for KindredBio, and it

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415